Home › High Blood Pressure › NCT05184933
Sleep and Circadian Mechanisms in Hypertension
Recruiting
Who can join
Ages 25 to 64 · All sexes
Full eligibility criteria
Inclusion Criteria: * Ages 25-64 * BMI 18.5-42kg/m2 * Hypertension (average resting blood pressure between 130/80 mmHg and 160/100 mmHg) Exclusion Criteria: * Over 5 pack-years of smoking; * Prior shift work within 12 months prior to the study; * Travel greater than three time zones for at least 3 months; * History of heart failure, cardiomyopathy, or history of bypass surgery, angioplasty, or previous myocardial infarction; * Acute or chronic diseases (except hypertension) that may affect outcome measures; * History of psychological conditions; * Sleep disorders, like severe sleep apnea, insomnia, etc.; * Prescription medications (Contraceptives and anti-hypertensive medications are permissible); * History of Illicit drug use and alcohol dependency; * 30 days free of cannabis use prior to the study; * Pregnancy; * Upper cut-off of 160/100 mmHg for BP
About the study
This study is a mechanistic clinical trial designed to investigate the effects of the circadian system and sleep on non-dipping blood pressure (BP) in people with hypertension (HTN).
What is being tested
- At-home Polysomnography (other)
- Circadian Protocol (other)
- Rested Wakefulness Trial (other)
- Overnight Sleep Trial (other)
- Regularized Sleep Schedule (behavioral)
Sponsor: Oregon Health and Science University · Participants: 32 · Started: Aug 4, 2022
Contact the study team
- Nicole Chaudhary, MPH · Phone: 5034945536
Official record on ClinicalTrials.gov — NCT05184933
Locations in the U.S.
| Oregon | Oregon Health and Science University, Portland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.